Early and late brain resonance findings of two siblings with Hunter syndrome

J J Silvestre-Avendaño1,2,3, D E Morales-Vásquez2, J R Muñoz-Zuñiga4,2

  • 1Universidad Nacional de Colombia, Bogotá DC, Colombia.

Revista De Neurologia
|June 25, 2021
PubMed
Abstract

Insights

Mucopolysaccharidosis type II (MPS II), a genetic disorder, can manifest differently in siblings. Brain MRI is a crucial early diagnostic tool for MPS II, identifying brain changes before other symptoms appear.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Mucopolysaccharidosis type II (MPS II) is an X-linked lysosomal storage disease.
  • It results from a deficiency in the enzyme iduronate-2-sulfatase (IDS).
  • MPS II presents with a broad spectrum of clinical manifestations.

Observation:

  • Two siblings with MPS II, sharing the same genetic mutation but of different paternal origin, were studied.
  • Case 1 was diagnosed at 5 years old, while Case 2 was diagnosed at 8 months old.
  • Brain MRI revealed distinct findings between the siblings.

Findings:

  • Case 1 showed classic age-appropriate MRI findings.
  • Case 2 exhibited early, significant MRI abnormalities, including dilated perivascular spaces (up to 9.5 mm) and magna megacisterna.
  • These early findings in Case 2 occurred without neurological manifestations.

Implications:

  • Brain compromise in MPS II can be evident before one year of age and prior to hepatosplenomegaly.
  • Brain magnetic resonance imaging (MRI) serves as a valuable early diagnostic tool for MPS II.
  • Early diagnosis through MRI enables timely intervention and management of MPS II.

Related Concept Videos